261 related articles for article (PubMed ID: 33331525)
21. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
Haq M; Rehman A; Ahmad J; Zafar U; Ahmed S; Khan MA; Naveed A; Rajab H; Muhammad F; Naushad W; Aman M; Rehman HU; Ahmad S; Anwar S; Haq NU
Infection; 2021 Oct; 49(5):983-988. PubMed ID: 34032997
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
26. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
Núñez-Zapata SF; Benites-Peralta B; Mayta-Tristan P; Rodríguez-Morales AJ
Int J Infect Dis; 2021 Aug; 109():244-246. PubMed ID: 34260956
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea.
Noh JY; Seo YB; Yoon JG; Seong H; Hyun H; Lee J; Lee N; Jung S; Park MJ; Song W; Yoon J; Lim CS; Ryou J; Lee JY; Kim SS; Cheong HJ; Kim WJ; Yoon SY; Song JY
J Korean Med Sci; 2020 Aug; 35(33):e311. PubMed ID: 32830472
[TBL] [Abstract][Full Text] [Related]
28. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
29. [Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic].
Popova AY; Smirnov VS; Ezhlova EB; Mel'nikova AA; Samoilova LV; Lyalina LV; Semenova EV; Gurskiy MA; Aksenova EA; Arbuzova TV; Totolian AA
Vopr Virusol; 2021 Sep; 66(4):299-309. PubMed ID: 34545722
[TBL] [Abstract][Full Text] [Related]
30. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
31. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.
Kugeler KJ; Podewils LJ; Alden NB; Burket TL; Kawasaki B; Biggerstaff BJ; Biggs HM; Zacks R; Foster MA; Lim T; McDonald E; Tate JE; Herlihy RK; Drobeniuc J; Cortese MM
Public Health Rep; 2022; 137(1):128-136. PubMed ID: 34752156
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Rodrigues Bomfim R; Grespan R; Santana Rodrigues L; Dos Santos DM; de Sá Resende A; de Lima Silva N; da Silva Santos ACR; Dantas Araújo JM; de Souza MF; de Oliveira Góes MA; Santana Santos V; Martins-Filho PR
Epidemiol Infect; 2021 May; 149():e130. PubMed ID: 34001292
[TBL] [Abstract][Full Text] [Related]
33. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
George CE; Inbaraj LR; Rajukutty S; Joan RF; Suseeladevi AK; Muthuraj S; Chandrasingh S
PLoS One; 2022; 17(3):e0265236. PubMed ID: 35271669
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
Herlinda O; Bella A; Kusnadi G; Swasthika Nurshadrina D; Thoriq Akbar M; Nida S; Salama N; Ariawan I; Saminarsih D
PLoS One; 2021; 16(12):e0261931. PubMed ID: 34941968
[TBL] [Abstract][Full Text] [Related]
36. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
37. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
[TBL] [Abstract][Full Text] [Related]
38. Population Immunity Against COVID-19 in the United States.
Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP
Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
40. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
